ISPUB.com / IJNUC/2/2/11154
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Nuclear Medicine
  • Volume 2
  • Number 2

Original Article

Myocardial Uptake of 99m-Tc-DPD in a Patient with Prostate Carcinoma

L Freudenberg, A Hopfenbach, J Esser, W Koska, A Conrads

Keywords

99m-tc-dpd, myocardial uptake, prostate carcinoma

Citation

L Freudenberg, A Hopfenbach, J Esser, W Koska, A Conrads. Myocardial Uptake of 99m-Tc-DPD in a Patient with Prostate Carcinoma. The Internet Journal of Nuclear Medicine. 2004 Volume 2 Number 2.

Abstract

We report a 77 year old patient with prostate carcinoma showing benign myocardial uptake of 99m-Tc-DPD in routine bone scintigraphy. Complementary diagnostic examinations were performed showing no incidence of systemic heart disease (amyloidosis, hypercalcimia). No previous chemotherapy or cardioversion were performed. Consequently we conclude, the myocardial uptake was secondary to the prostate carcinoma.

 

Case-Report

A 77-year-old male patient was admitted to Nuclear Medicine for staging of a prostate carcinoma prior to surgery. Planar whole body bone scintigraphy was performed on a Genesys gamma-camara (Single Head, ADAC) 3 h after i.v. administration of 670 MBq of 99m-Tc-DPD showing no evidence of bone metastasis but an intensive myocardial tracer-uptake (Figure 1). Consecutive Single Photon Emission Computed Tomography (SPECT) imaging of thorax was aquired demonstrating homogeneous tracer-uptake of the left ventricle (Figure 2).

Figure 1
Figure 1: Planar images (3 h p.i. 670 MBq of 99m-Tc-DPD) showing no evidence of bone metastasis but an intensive myocardial tracer-uptake.

Figure 2
Figure 2: SPECT imaging of thorax (3.5. h p.i. 670 MBq of 99m-Tc-DPD) demonstrate homogeneous tracer-uptake of the left ventricle.

Subsequent clinical workup showed a normally developed asymptomatic patient with normal physical examinations. No previous chemotherapy or cardioversion were performed. Routine laboratory results revealed no pathologic abnormalities including plasma electrolytes. Complementary cardiological examinations were performed showing no incidence of systemic heart disease.

Discussion

Benign myocardial uptake of technetium-99m labelled phosphates has been documented in patients with amyloidosis. Literature described several cases of abnormal myocardial uptake of various bone-imaging tracers in various disease states [1, 2]. Furthermore myocardial uptake of bone tracers was described in other conditions with systemic heart disease [3] or in association with secondary hyperparathyroidism [4].

Besides myocardial uptake of 99m-Tc-HDP and 99mTc-MDP was documented in association with malignant tumours in general [5, 6] and prostatic carcinoma in particular [7, 8]. Most of these patients were over 80 years of age [8]. Although uptake of radiophosphates is attributed to asymptomatic atherosclerotic changes associated with old age, a strong association with prostatic carcinoma exists, which following al-Nahhas et al. [8] indicate variations in soft tissue affinity of different radiophosphates complexes.

Conclusion

We presented a case of abnormal myocardial 99m-Tc-DPD-uptake in a patient without evidence of any cardiac or noncardiac disorder that might account for such uptake. Thus, we conclude, the myocardial uptake was secondary to the prostate carcinoma.

Correspondence to

Dr. med. Lutz S. Freudenberg, M.A., M.B.A., Oec. med. (BI) Nuclear Medicine Röntgeninstitut Grevenbroich Karl-Oberbach-Strasse 19 D-41515 Grevenbroich Germany Tel: +49 / 2181 2259-15 Fax: +49 / 2181 2259-29 Email: l.freudenberg@t-online.de

References

1. Kulhanek J, Movahed A. Uptake of technetium 99m HDP in cardiac amyloidosis. Int J Cardiovasc Imaging. 2003 Jun;19(3):225-7.
2. Low YH, Ang ES, Goh AS, Sundram FX, Sin FL. Technetium-99m (Tc-99m) diphosphono-propanedicarboxylic acid bone tracer uptake and Tc-99m sestamibi distribution in cardiac amyloidosis--a case report. Ann Acad Med Singapore. 1995 Nov;24(6):898-901.
3. Macdonald WB, Troedson RG. Unexpected myocardial uptake on bone scintigraphy in an infant with Kawasaki Disease. Clin Nucl Med. 2001 May;26(5):455.
4. Kida T, Hujita Y, Sasaki M, Inoue J. Myocardial and vascular uptake of a bone tracer associated with secondary hyperparathyroidism.Eur J Nucl Med. 1986;12(3):151-4.
5. Low RD, Hicks RJ, Arkles LB, Gill G, Adam W. Progressive soft tissue uptake of Tc-99m MDP reflecting metastatic microcalcification. Clin Nucl Med. 1992 Aug;17(8):658-62.
6. Kaida H, Ishibashi M, Baba K, Nishida H, Matsuoka K, Hayabuchi N. Extraosseous uptake of metastatic lymph nodes of ureteral cancer on 99Tcm hydroxymethylene diphosphonate bone scintigraphy. Br J Radiol. 2004 Oct;77(922):869-70.
7. Poblete Garcia VM, Rodado Marina S, Garcia Vicente A, Soriano Castrejon A. Benign myocardial uptake of 99mTc-HMDP in prostate carcinoma: based on three cases Rev Esp Med Nucl. 2003 Jan-Feb;22(1):35-9.
8. al-Nahhas AM, Jinnouchi S, Anagnostopoulos C, Hirsch W, Heary T, McCready VR. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate. Eur J Nucl Med. 1995 Feb;22(2):148-53.

Author Information

L. S. Freudenberg
Röntgeninstitut Grevenbroich

A. Hopfenbach
Röntgeninstitut Grevenbroich

J. Esser
Röntgeninstitut Grevenbroich

W. W. Koska
Röntgeninstitut Grevenbroich

A. Conrads
Röntgeninstitut Grevenbroich

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy